FFFatemeh Dehghani Firouzabadi

Fatemeh Dehghani Firouzabadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fatemeh Dehghani Firouzabadi has a total of 149 co-authors. Here are the top co-authors by number of shared publications:

  • Alireza Esteghamati

    Endocrinology and Metabolism Research Center (EMRC) Vali‐Asr Hospital, Tehran University of Medical Sciences Tehran Iran

    6 shared publications
  • Mohammad Dehghani Firouzabadi

    ENT and Head and Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Fatemeh Moosaie

    Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Manouchehr Nakhjavani

    Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Sogand Goudarzi

    ENT and Head & Neck Research Center, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran; Department of Otolaryngology-Head and Neck Surgery, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran; Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States

    4 shared publications
  • Hesam Jahandideh

    ENT and Head & Neck Research Center, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran; Department of Otolaryngology-Head and Neck Surgery, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran

    3 shared publications

Latest Publications

  • Open Access

    Association between central obesity and MRI-based biomarkers of knee osteoarthritis independent of BMI: A cross-sectional study from the Osteoarthritis Initiative database

    by Gabby B. Joseph, Fatemeh Dehghani Firouzabadi, John A. Lynch, Zehra Akkaya, Nancy E. Lane, Michael C. Nevitt, Charles E. McCulloch, Thomas M. Link

  • Open Access

    State of the art review of AI in renal imaging

    by Ali Sheikhy, Fatemeh Dehghani Firouzabadi, Nathan Lay, Negin Jarrah, Pouria Yazdian Anari, Ashkan Malayeri

    Renal cell carcinoma (RCC) as a significant health concern, with incidence rates rising annually due to increased use of cross-sectional imaging, leading to a higher detection of incidental renal lesions. Differentiation between benign and malignant renal lesions is essential for effective treatment planning and prognosis. Renal tumors present numerous histological subtypes with different prognoses, making precise subtype differentiation crucial. Artificial intelligence (AI), especially machine learning (ML) and deep learning (DL), shows promise in radiological analysis, providing advanced tools for renal lesion detection, segmentation, and classification to improve diagnosis and personalize treatment. Recent advancements in AI have demonstrated effectiveness in identifying renal lesions and predicting surveillance outcomes, yet limitations remain, including data variability, interpretability, and publication bias. In this review we explored the current role of AI in assessing kidney lesions, highlighting its potential in preoperative diagnosis and addressing existing challenges for clinical implementation.


  • Open Access

    Prevalence of metabolic dysfunction–associated fatty liver disease among patients with diabetic kidney disease: a systematic review and meta-analysis

    by Mohammad Rahmanian, Niloofar Deravi, Mohadeseh Poudineh, Amirhossein Poopak, Seyed Nooshan Mirmohammadali, Saba Fekrvand, Kiana Tadbir, Sara Ebrahimian, Nikan Zargarzadeh, Marzieh Pirzadeh, et al.

    Background: Mechanistic relationships between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease are well characterized. Specifically, in type 2 diabetes (T2D), insulin resistance leads to MAFLD, and hyperglycemia leads to microvascular complications such as diabetic kidney disease (DKD). This systematic review and meta-analysis aims to describe the specific association between MAFLD and DKD for the first time. Methods: PubMed, Web of Science, Google Scholar, and Scopus databases were searched up to February 2023 to identify relevant published articles. After screening the titles, abstracts, and full texts of the retrieved articles, cross-sectional studies and cohorts reporting on MAFLD in patients with DKD were identified and then analyzed. Results: A total of 2615 articles were identified, of which 5 had sufficient data and fulfilled the eligibility criteria for meta-analysis. A total of 2345 patients with DKD were in the included studies. The prevalence rates of radiologically diagnosed MAFLD among patients with DKD ranged from 25 to 96%. The pooled prevalence rate of radiologically diagnosed MAFLD among patients with DKD was 0.55 (95% CI = 0.21–0.89, I2 = 99.79%, P-value < 0.01). Conclusion: MAFLD is prevalent in patients with DKD. This finding emphasizes the need for aggressive case finding and then guideline-directed medical therapy of MAFLD, especially in patients with T2D and DKD to prevent further complications. Future studies should investigate mechanisms underpinning MAFLD and DKD in patients with T2D, especially in the context of cardiometabolic risk.

  • Predicting post-surgical complications using renal scoring systems

    by Mahshid Golagha, Charles Hesswani, Shiva Singh, Fatemeh Dehghani Firouzabadi, Ali Sheikhy, Christopher Koller, W. Marston Linehan, Mark W. Ball, Ashkan A. Malayeri

    Current surgical approaches for renal malignancies primarily rely on qualitative factors such as patient preferences, surgeon experience, and hospital capabilities. Applying a quantitative method for consistent and reliable assessment of renal lesions would significantly enhance surgical decision-making and facilitate data comparison. Nephrometry scoring (NS) systems systematically evaluate and describe renal tumors based on their anatomical features. These scoring systems, including R.E.N.A.L., PADUA, MAP scores, C-index, CSA, and T-index, aim to predict surgical complications by evaluating anatomical and patient-specific factors. In this review paper, we explore the components and methodologies of these scoring systems, compare their effectiveness and limitations, and discuss their application in advancing patient care and optimizing surgical outcomes.

  • Morning Glory Disc Anomaly: Expanding the MR Phenotype

    by F.D. Firouzabadi, M D Soldatelli, V. Rameh, G. Heidary, S.O. Vargas, E. Gonzalez, J. Rispoli, R. Rahbar, C.D. Robson

    BACKGROUND AND PURPOSE: Morning glory disc anomaly (MGDA) is a congenital malformation characterized by a funnel-shaped optic disc excavation with radiating vessels and a central glial tuft. Imaging is essential to evaluate associated cephalocele and steno-occlusive vasculopathy. The goal of this study was to assess optic nerve, chiasmatic, and sphenoid bone morphology in MGDA. MATERIALS AND METHODS: This retrospective study examined all subjects with funduscopically confirmed MGDA diagnosed and imaged with brain MR imaging between 2008 and 2023. RESULTS: Thirty-two children met inclusion criteria. Ocular involvement was unilateral in 29 subjects and bilateral in 3. Segmental optic nerve enlargement ipsilateral to the MGDA was seen in 21 subjects, with 3 also demonstrating a segmental reduction in the size of the ipsilateral optic nerve. Segmental reduction in the size of the ipsilateral optic nerve was present in 3 additional subjects, one with bilateral MGDA. The optic chiasm appeared asymmetrically thickened in 21 subjects, often with deformity. The optic nerves appeared normal in signal intensity in all subjects, with faint peripheral chiasmatic enhancement in 4 of 20 patients who received contrast. Optic nerve findings were stable in 15 subjects with multiple examinations. A persistent craniopharyngeal canal was identified in 17 subjects with sphenoid cephalocele in 1 and mild inferior pituitary gland displacement in 4. Tubular or nodular nasopharyngeal lesions were seen in 10 subjects. One subject had an off-midline sphenoid bone cleft, midbrain deformity, and abnormal thickening of and enhancement around the left oculomotor nerve; the oculomotor nerve finding was present in 1 additional patient. CONCLUSIONS: MGDA often manifests with ipsilateral optic nerve thickening, leading to a potential misdiagnosis as optic glioma. MGDA is also commonly associated with a persistent craniopharyngeal canal with variable pituitary gland and infundibular deformity, cephalocele, and tubular or nodular nasopharyngeal lesions.


  • Open Access

    Endoscopic trans‐canal facial nerve decompression in Melkersson–Rosenthal syndrome: A novel approach

    by Alimohamad Asghari, Yaser Nasoori, Ahmad Daneshi, Mojgan Kianiasiabar, Fatemeh Dehghani Firouzabadi

    Key Clinical Message: Melkersson–Rosenthal syndrome can cause recurring bilateral facial paralysis. When steroids fail, surgical decompression of facial nerve is recommended, with endoscopic trans‐canal decompression as a safe, minimally invasive, and effective option. Melkersson–Rosenthal syndrome (MRS) is a rare neuro‐mucocutaneous disorder, clinically diagnosed by a triad of orofacial swelling, recurrent facial palsy, and fissured tongue. Due to the lack of a comprehensive understanding of MRS, there is no accepted standard of care. In this study we report a 30‐year‐old female patient, who was referred to the otolaryngology clinic of Rasool Akram Hospital, with classical triad of MRS that was managed by endoscopic trans‐canal facial nerve decompression. Bilateral endoscopic trans‐canal facial nerve decompression was done when we did not find any improvement with systemic steroids. Endoscopic trans‐canal facial nerve decompression could be a safe, reliable minimal invasive treatment of facial paralysis in MRS patients. It needs no external incision or temporal bone drilling which makes this method more convenient for patients with shorter recovery time.

  • Prevalence of diabetic neuropathy in nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta-analysis

    by Mohammad Rahmanian, Shirin Yaghoobpoor, Niloofar Deravi, Mohadeseh Poudineh, Seyedeh Nooshan Mirmohammadali, Mohammad Ghasem Kashanizadeh, Amirhossein Poopak, Arezoo Faridzadeh, Gisou Erabi, Erfan Amouei, et al.

  • The role of arachnoid granulations in idiopathic intracranial hypertension

    by Fahimul Huda, Ahmed Abdelmonem, Fatemeh Dehghani Firouzabadi, Venkata Naga Srinivas Dola, Ali Sheikhy, M Reza Taheri

    Objectives: Idiopathic intracranial hypertension (IIH) is a disease defined by elevated intracranial pressure (ICP) without an established etiology. Arachnoid granulations (AG) are conduits for CSF resorption from the subarachnoid space to the venous system. AG have been implicated to play a central role in maintaining CSF homeostasis. We tested the hypothesis that patients with fewer visible AG on MRI are more likely to present with IIH. Methods: In this institutional review board (Institutional Review Board)-approved retrospective chart review study, 65 patients with a clinical diagnosis of idiopathic intracranial hypertension were compared to 144 control patients who met inclusion/exclusion criteria. Patients’ signs and symptoms pertaining to IIH were obtained through the electronic medical record Brain MR images were reviewed for the number and distribution of AGs indenting the dural venous sinuses. The presence of imaging and clinical findings associated with long standing increased ICP was noted. Propensity score method (with inverse probability weighting technique) was used to compare case and control groups. Results: In the control group, the number of AG indenting the dural venous sinuses on MRI (NAG) was lower in women compared to men when matched for age (20–45 yo) and BMI (>30 kg/m2). The NAG was lower in 20–45 yo females in the IIH group as compared to the 20–45 yo females in the control group. This statistically significant difference persists when controlled for BMI. In contrast, the NAG in >45 yo females in the IIH group trended higher compared to the >45 yo females in the control group. Conclusion: Our results suggest that alterations in arachnoid granulations could play a role in the development of IIH.


  • Open Access

    The outcome of olfactory impairment in patients with otherwise paucisymptomatic coronavirus disease 2019 during the pandemic

    by M Jalessi, S H Bagheri, Z Azad, F D Firouzabadi, E Amini, R Alizadeh, S Chaibakhsh, B Ghalehbaghi, C Hopkins, M Farhadi

    Objective This study aimed to measure the duration and recovery rate of olfactory loss in patients complaining of recent smell loss as their prominent symptom during the coronavirus disease 2019 outbreak. Method This was a prospective telephone follow-up observational study of 243 participants who completed an online survey that started on 12 March 2020. Results After a mean of 5.5 months from the loss of smell onset, 98.3 per cent of participants reported improvement with a 71.2 per cent complete recovery rate after a median of 21 days. The chance of complete recovery significantly decreased after 131 days from the onset of loss of smell (100 per cent sensitive and 97.7 per cent specific). Younger age and isolated smell loss were associated with a rapid recovery, whereas accompanying rhinological and gastrointestinal symptoms were associated with longer loss of smell duration. Conclusion Smell loss, occurring as a prominent symptom during the coronavirus disease 2019 pandemic, showed a favourable outcome. However, after 5.5 months from the onset, around 10 per cent of participants still complained of moderate or severe hyposmia.


  • Open Access

    Pulmonary embolism in pregnancy with COVID‐19 infection: A case report

    by Sogand Goudarzi, Fatemeh Dehghani Firouzabadi, Fatemeh Mahmoudzadeh, Soheila Aminimoghaddam

    Pregnant women in the third trimester are at the highest risk. Contracting COVID‐19 increases the complications. Hence, it is critical for pregnant women, especially during the third trimester, with slightest COVID‐19 symptoms to visit as soon as possible. Early diagnosis considerably contributes to saving both the mother and the fetus.